Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccination may trigger lupus in some people.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Quercetin effectively treated and prevented hair loss in mice.

Hair gels may cause split ends in children.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Topical treatments led to hair regrowth in a man with linear morphea.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Apremilast did not work for treating severe alopecia areata.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Trichoscopy is a non-invasive way to diagnose hair and scalp problems without needing hair samples.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

CD2 might be a new treatment target for patchy alopecia areata.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.